Contrasting effects of fluoroquinolone antibiotics on the expression of the collagenases, matrix metalloproteinases (MMP)-1 and -13, in human tendon-derived cells

Rheumatology

Volumn 44, Issue 12, 2005, Pages 1514-1517

  Corps, A N ^a   Harrall, R L ^a   Curry, V A ^a   Hazleman, B L ^a   Riley, G P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Collagenase; Fluoroquinolone; Interleukin; Matrix metalloproteinase; Tendon

Indexed keywords

CIPROFLOXACIN; COLLAGENASE; COLLAGENASE 3; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INCUBATION TIME; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENDON;

ACHILLES TENDON; ANTI-INFECTIVE AGENTS; CELLS, CULTURED; COLLAGENASES; FLUOROQUINOLONES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 28544443116     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei087     Document Type: Article

References (19)

1. Ball P, Mandell L, Niki Y, Tillotson G. Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf 1999;21:407-21.
2. De Sarro A, De Sarro G. Adverse reactions to fluoroquinolones: An overview on mechanistic aspects. Curr Med Chem 2001;8:371-84.
3. Stahlmann R, Lode H. Fluoroquinolones in the elderly: Safety considerations. Drugs Aging 2003;20:289-302.
4. Dalhoff A, Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis 2003;3:359-71.
5. Pierfitte C, Royer RJ. Tendon disorders with fluoroquinolones. Therapie 1996;51:419-20.
6. van der Linden PD, van Puijenbroek EP, Feenstra J et al. Tendon disorders attributed to fluoroquinolones: A study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum 2001;45:235-9.
7. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: A critical review of the literature. Clin Infect Dis 2003;36:1404-10.
8. van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 2003;163:1801-7.
9. Burkhardt JE, Hill MA, Lamar CH, Smith GN Jr, Carlton WW. Effects of difloxacin on the metabolism of glycosaminoglycans and collagen in organ cultures of articular cartilage. Fundam Appl Toxicol 1993;20:257-63.
10. Williams RJ, Attia E, Wickiewicz TL, Hannafin JA. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med 2000;28:364-9.
11. Simonin M-A, Gegout-Pottie P, Minn A, Gillet P, Netter P, Terlain B. Pefloxacin-induced Achilles tendon toxicity in rodents: Biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob Agents Chemother 2000;44:867-72.
12. Corps AN, Harrall RL, Curry VA, Fenwick SA, Hazleman BL, Riley GP. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum 2002;46:3034-40.
13. Movin T, Gad A, Guntner P, Foldhazy Z, Rolf C. Pathology of the Achilles tendon in association with ciprofloxacin treatment. Foot Ankle Int 1997;18:297-9.
14. Ireland D, Harrall RL, Holloway G, Hackney R, Hazleman BL, Riley GP. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001;20:159-69.
15. Corps AN, Curry VA, Buttle DJ, Hazleman BL, Riley GP. Inhibition of interleukin-1beta-stimulated collagenase and stromelysin expression in human tendon fibroblasts by epigallocatechin gallate ester. Matrix Biol 2004;23:163-9.
16. 2 output by interleukin-1b in human tendon-derived cells. Rheumatology 2003;42:1306-10.
17. Pouzaud F, Bernard-Beaubois K, Thevenin M, Warnet J-M, Hayem G, Rat P. In vitro discrimination of fluoroquinolones toxicity on tendon cells: involvement of oxidative stress. J Pharmacol Exp Ther 2004;308:394-402.
18. Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 2002;4:157-64.
19. Kashida Y, Kato M. Characterization of fluoroquinolone-induced Achilles tendon toxicity in rats: Comparison of toxicities of 10 fluoroquinolones and effects of anti-inflammatory compounds. Antimicrob Agents Chemother 1997;41:2389-93.